peroxynitrous acid has been researched along with Diabetic Angiopathies in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, Y; Tong, F; Wang, ZB; Wen, JK; Yang, BM; Yang, Z; Zhang, ML; Zhang, XH; Zhao, YL; Zheng, B | 1 |
| Gaillard, F; Lazareth, H; Lenoir, O; Robin, B; Tharaux, PL | 1 |
| Fu, F; Ji, L; Li, J; Liang, X; Sun, X; Tian, F; Tie, R; Xing, J; Xing, W; Zhang, H; Zhang, W | 1 |
| Tessari, P | 1 |
| Kobayashi, T | 1 |
| Szabo, C | 1 |
| Abbott, L; Gao, X; Park, Y; Wilson, E; Yang, J; Zhang, C; Zhang, H; Zimmer, W | 1 |
| Borowiec, J; Huang, X; Jacob, RF; Kubant, R; Louka, FR; Malinski, P; Malinski, T; Mason, RP; Mizuno, Y | 1 |
| Caldwell, RB; Caldwell, RW; El-Remessy, AB; Matragoon, S; Pillai, B; Tawfik, HE | 1 |
| Jakus, J; Jenei, V; Somogyi, A; Stadler, K; von Bölcsházy, G | 1 |
| Stepuro, II | 1 |
| Mabley, JG; Obrosova, IG; Pacher, P; Szabó, C | 1 |
| Abraham, NG; Fusco, H; Goligorsky, MS; Goodman, AI; Kappas, A; Kruger, AL; McClung, JA; Peterson, SJ; Schwartzman, ML; Shenouda, S; Weiss, M | 1 |
| Drel, VR; Groves, JT; Mashtalir, N; Obrosova, IG; Oltman, CL; Tibrewala, J; Yorek, MA | 1 |
| Esposito, K; Giugliano, D; Marfella, R | 1 |
5 review(s) available for peroxynitrous acid and Diabetic Angiopathies
| Article | Year |
|---|---|
Nitric oxide in the normal kidney and in patients with diabetic nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Gases; Humans; Hydrogen Sulfide; Hypoglycemic Agents; Inflammation Mediators; Kidney; Mineralocorticoid Receptor Antagonists; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Signal Transduction | 2015 |
[Possible involvement of insulin and oxidative stress in vascular dysfunction of diabetic mellitus].
Topics: Animals; Calcium-Transporting ATPases; Diabetic Angiopathies; Endothelium, Vascular; Humans; Hyperinsulinism; Insulin; Muscle Relaxation; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Sarcoplasmic Reticulum | 2008 |
Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.
Topics: Aldehyde Reductase; Angiotensin II; Animals; Diabetic Angiopathies; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Activation; Glucose; Glycation End Products, Advanced; Humans; Oxidative Stress; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Protein Kinase C; Reactive Nitrogen Species; Reactive Oxygen Species; Signal Transduction | 2009 |
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
Topics: Animals; Cardiomyopathies; Diabetes Complications; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Endothelium, Vascular; Humans; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Superoxides; Tyrosine | 2005 |
Hyperglycemia and heart dysfunction: an oxidant mechanism contributing to heart failure in diabetes.
Topics: Animals; Cardiac Output, Low; Diabetic Angiopathies; Heart; Humans; Hyperglycemia; Oxidants; Oxidative Stress; Peroxynitrous Acid; Superoxide Dismutase; Superoxides | 2002 |
10 other study(ies) available for peroxynitrous acid and Diabetic Angiopathies
| Article | Year |
|---|---|
iNOS-derived peroxynitrite mediates high glucose-induced inflammatory gene expression in vascular smooth muscle cells through promoting KLF5 expression and nitration.
Topics: Diabetic Angiopathies; Female; Glucose; Humans; Inflammation; Kruppel-Like Transcription Factors; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type II; Peroxynitrous Acid | 2017 |
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Genetic Predisposition to Disease; Heme Oxygenase-1; Kidney; Kidney Glomerulus; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oxidative Stress; Peroxynitrous Acid; Streptozocin | 2017 |
Alpha-linolenic acid intake prevents endothelial dysfunction in high-fat diet-fed streptozotocin rats and underlying mechanisms.
Topics: alpha-Linolenic Acid; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, High-Fat; Dietary Supplements; Dose-Response Relationship, Drug; Endothelium, Vascular; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Phosphorylation; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxides; Vasodilation; Vasodilator Agents | 2013 |
Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.
Topics: Animals; Arterioles; Biomarkers; Chemokine CCL2; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; I-kappa B Proteins; Inflammation Mediators; Macrophages; Male; Mice; Mice, Knockout; NF-kappa B; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Phosphorylation; Receptors, Leptin; Serine; Signal Transduction; Superoxides; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Cell Adhesion Molecule-1; Vasodilation; Vasodilator Agents | 2009 |
Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Arteries; Benzopyrans; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelial Cells; Ethanolamines; Hypertension; Kidney; Male; Metoprolol; Nebivolol; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2009 |
Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation.
Topics: Animals; Aorta; Biomarkers; Cattle; Cells, Cultured; Coronary Vessels; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Activation; Gene Expression Regulation, Enzymologic; Hyperglycemia; In Vitro Techniques; Male; Metalloporphyrins; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Protein Kinase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; RNA, Messenger; Vasodilation | 2010 |
[Role of free radicals and reactive nitrogen species in the late complications of diabetes mellitus in rats].
Topics: Aging; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Free Radicals; Male; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Wistar; Reactive Nitrogen Species; Urothelium | 2004 |
Thiamine and vasculopathies.
Topics: Diabetic Angiopathies; Humans; Hydrogen-Ion Concentration; Models, Biological; Oxidation-Reduction; Peroxynitrous Acid; Proteins; Thiamine | 2005 |
Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects.
Topics: Animals; Antioxidants; Apoptosis; bcl-X Protein; Blood Pressure; Blotting, Western; Diabetic Angiopathies; Endothelial Cells; Heme Oxygenase (Decyclizing); Hypertension; Male; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxygen; Oxygen Consumption; p38 Mitogen-Activated Protein Kinases; Peroxynitrous Acid; Phosphorylation; Rats; Rats, Zucker; Signal Transduction; Tyrosine; Up-Regulation | 2006 |
Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
Topics: Animals; Aorta; Arterioles; Blood Glucose; Body Weight; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Neuropathies; Ganglia, Spinal; Hyperalgesia; Hypoglycemic Agents; Male; Mesenteric Arteries; Metalloporphyrins; Neural Conduction; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Rats; Rats, Wistar; Regional Blood Flow; Sciatic Nerve; Superoxides; Tyrosine; Vasodilator Agents | 2007 |